Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

flag-en
flag-de
flag-es
flag-fr
flag-it
flag-ja
flag-ko
flag-zh
x
flag-en
flag-de
flag-es
flag-fr
flag-it
flag-ja
flag-ko
flag-zh

This content is available also in other languages

NGS applications

NGS technologies are transforming life science research and enabling scientists to gain a large wealth of information. Tecan’s proprietary technologies enable researchers to simplify their workflows and gain more information with each sequencing run thus saving time and money. Learn more about the research that is being done globally with Tecan’s NGS products.




***************************************************************************************
***************************************************************************************
Tab 01 / Cancer
***************************************************************************************
***************************************************************************************




***************************************************************************************
***************************************************************************************
Tab 02 / Infectious Disease
***************************************************************************************
***************************************************************************************




***************************************************************************************
***************************************************************************************
Tab 03 / Liquid Biopsy
***************************************************************************************
***************************************************************************************

Every drop counts:
Maximize biomarker discovery

Liquid biopsies are performed on a fluid sample such as blood, and typically monitor circulating tumor cells, cell-free DNA or cell-free RNA, or RNA from exosomes to find changes in genetic biomarkers. Such cell-free DNA or RNA tests can provide a less-expensive and less-invasive way to track cancer and when combined with next-generation sequencing technologies, enable researchers to screen thousands of biomarkers in one sample.

Tecan’s unique technologies enable highly efficient sample preparation of DNA or RNA from liquid biopsy samples to maximize biomarker research and discovery

Profiling biomarkers: Gene expression to predict tumors Profiling biomarkers: Gene expression to predict tumors

Profiling biomarkers: Gene expression to predict tumors

Dr. Moshayoff and coworkers utilized the Ovation® PicoSL WTA System to further their research into the characterization profile of early-stage colorectal cancer (CRC) and advanced adenomas (AA). Combining current molecular knowledge with whole-transcriptome profiling of cell-free RNA, the team defines a panel of markers to further CRC and AA research.

Read the publication

 

NGS analysis of blood samples: globin depletion NGS analysis of blood samples: Globin depletion

Cell-free approach: New NIPT test method

Transcriptome analysis from whole blood using NGS is an unbiased approach for biomarker research and discovery. However, one of the major challenges when performing whole blood mRNA-Seq is the presence of significant amounts of globin mRNA (up to 80 %) that usurps sequencing space without providing useful biological information. The paper describes a streamlined workflow for mRNA-Seq from whole blood using the Universal Plus mRNA-Seq library prep kit with Human Globin AnyDeplete.

Read the application

 

Methylated biomarkers: A new tool for liquid biopsy Methylated biomarkers: A new tool for liquid biopsy

Methylated biomarkers: A new tool for liquid biopsy

Legendre and Gooden et. al. analyze cell free DNA in breast cancer patients and healthy individuals. Using the Ovation® Ultralow Methyl-Seq Library System, the authors research tumor-specific signatures and identify 21 hypermethylation hotspots associated with metastatic breast cancer.

Read the publication

 




***************************************************************************************
***************************************************************************************
Tab 04 / Agrigenomics
***************************************************************************************
***************************************************************************************




***************************************************************************************
***************************************************************************************
Tab 05 / Microbiomics
***************************************************************************************
***************************************************************************************